| Profile | GDS4177 / 211313_s_at |
| Title | Imatinib treatment of chronic myeloid leukemia cell lines: KU-812, KCL-22 and JURL-MK1 |
| Organism | Homo sapiens |
| Sample | Title | Value | Rank |
|---|---|---|---|
| GSM603100 | KU-812 Imatinib-treated | 39.55 | 54 |
| GSM603099 | KU-812 non-treated | 37.34 | 53 |
| GSM603098 | KCL-22 Imatinib-treated | 40.15 | 55 |
| GSM603097 | KCL-22 non-treated | 35.91 | 53 |
| GSM603102 | JURL-MK1 Imatinib-treated | 41.2 | 55 |
| GSM603101 | JURL-MK1 non-treated | 39.41 | 54 |